Literature DB >> 16127040

Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.

Mohammed I Al-Salabi1, Harry P de Koning.   

Abstract

Nucleobase and nucleoside transporters play central roles in the biochemistry of parasitic protozoa, as they lack the ability to synthesize purines de novo and are absolutely reliant upon purine salvage from their hosts. Furthermore, such transporters are potentially critical to the pharmacology of these important human pathogens, because they mediate the uptake of purine analogues, as well as some nonpurine drugs, that can be selectively cytotoxic to the parasites. We here report the first identification and characterization of a purine nucleobase transporter in Leishmania amastigotes. Uptake of [3H]hypoxanthine by Leishmania mexicana amastigotes was mediated by a single high-affinity transporter, LmexNBT1, with a Km of 1.6 +/- 0.4 microM and high affinity for adenine, guanine, and xanthine but low affinity for nucleosides and pyrimidine nucleobases. Allopurinol, an antileishmanial hypoxanthine analogue, was apparently taken up by the same transporter. Using [3H]allopurinol, a Km value of 33.6 +/- 6.0 microM was obtained. All evidence was compatible with a model of a single purine nucleobase transporter being expressed in amastigotes. Using various purine nucleobase analogues, a model for the interactions between hypoxanthine and the transporter's permeant binding site was constructed. The binding interactions were compared with those of the LmajNBT1 transporter in Leishmania major promastigotes and found to be very similar.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127040      PMCID: PMC1195421          DOI: 10.1128/AAC.49.9.3682-3689.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  59 in total

Review 1.  Treatment of visceral leishmaniasis.

Authors:  S Sundar
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

2.  Studies with the experimental antitumor agent 4-aminopyrazolo[3, 4-d]pyrimidine.

Authors:  R K SHAW; R N SHULMAN; J D DAVIDSON; D P RALL; E FREI
Journal:  Cancer       Date:  1960 May-Jun       Impact factor: 6.860

Review 3.  Nucleoside and nucleobase transporters in parasitic protozoa.

Authors:  Scott M Landfear; Buddy Ullman; Nicola S Carter; Marco A Sanchez
Journal:  Eukaryot Cell       Date:  2004-04

4.  Trypanosoma cruzi: 4-aminopyrazolopyrimidine in the treatment of experimental Chagas' disease.

Authors:  J L Avila; A Avila; E Muñoz; H Monzón
Journal:  Exp Parasitol       Date:  1983-10       Impact factor: 2.011

5.  Ultrastructural studies in 4-aminopyrazolopyrimidine (4-APP)-induced fatty liver.

Authors:  M Murakoshi; Y Osamura; K Watanabe
Journal:  Tokai J Exp Clin Med       Date:  1985-04

6.  Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance.

Authors:  Manal J Natto; Lynsey J M Wallace; Denise Candlish; Mohammed I Al-Salabi; Shona E Coutts; Harry P de Koning
Journal:  Exp Parasitol       Date:  2005-01-08       Impact factor: 2.011

7.  A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis.

Authors:  V N Das; A Ranjan; A N Sinha; N Verma; C S Lal; A K Gupta; N A Siddiqui; S K Kar
Journal:  J Assoc Physicians India       Date:  2001-06

8.  Effects of mevinolin, an inhibitor of cholesterol synthesis, on the morphological and functional responses of rat adrenal zona fasciculata to a prolonged treatment with 4-aminopyrazolo-pyrimidine.

Authors:  G Mazzocchi; P Rebuffat; A S Belloni; G Gottardo; V Meneghelli; G G Nussdorfer
Journal:  Anat Rec       Date:  1988-07

9.  Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.

Authors:  D J Nelson; C J Bugge; G B Elion; R L Berens; J J Marr
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

10.  Activity of oral drugs against Leishmania tropica in human macrophages in vitro.

Authors:  J D Berman; L S Lee
Journal:  Am J Trop Med Hyg       Date:  1983-09       Impact factor: 2.345

View more
  10 in total

1.  Symmetrical choline-derived dications display strong anti-kinetoplastid activity.

Authors:  Hasan M S Ibrahim; Mohammed I Al-Salabi; Nasser El Sabbagh; Neils B Quashie; Abdulsalam A M Alkhaldi; Roger Escale; Terry K Smith; Henri J Vial; Harry P de Koning
Journal:  J Antimicrob Chemother       Date:  2010-11-14       Impact factor: 5.790

Review 2.  Dependence of Leishmania parasite on host derived ATP: an overview of extracellular nucleotide metabolism in parasite.

Authors:  Kashika Arora; Ambak Kumar Rai
Journal:  J Parasit Dis       Date:  2018-12-01

Review 3.  Transporters for drug delivery and as drug targets in parasitic protozoa.

Authors:  S M Landfear
Journal:  Clin Pharmacol Ther       Date:  2009-07-01       Impact factor: 6.875

4.  2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.

Authors:  Boris Rodenko; Alida M van der Burg; Martin J Wanner; Marcel Kaiser; Reto Brun; Matthew Gould; Harry P de Koning; Gerrit-Jan Koomen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

5.  Predictive computational models of substrate binding by a nucleoside transporter.

Authors:  Catharine J Collar; Mohammed I Al-Salabi; Mhairi L Stewart; Michael P Barrett; W David Wilson; Harry P de Koning
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

6.  Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy.

Authors:  Khalid J H Alzahrani; Juma A M Ali; Anthonius A Eze; Wan Limm Looi; Daniel N A Tagoe; Darren J Creek; Michael P Barrett; Harry P de Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-04-20       Impact factor: 4.077

7.  Proteomic analysis of the secretome of Leishmania donovani.

Authors:  J Maxwell Silverman; Simon K Chan; Dale P Robinson; Dennis M Dwyer; Devki Nandan; Leonard J Foster; Neil E Reiner
Journal:  Genome Biol       Date:  2008-02-18       Impact factor: 13.583

8.  Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.

Authors:  Jane C Munday; Anthonius A Eze; Nicola Baker; Lucy Glover; Caroline Clucas; David Aguinaga Andrés; Manal J Natto; Ibrahim A Teka; Jennifer McDonald; Rebecca S Lee; Fabrice E Graf; Philipp Ludin; Richard J S Burchmore; C Michael R Turner; Andy Tait; Annette MacLeod; Pascal Mäser; Michael P Barrett; David Horn; Harry P De Koning
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

Review 9.  Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters.

Authors:  George Diallinas
Journal:  Front Pharmacol       Date:  2014-09-12       Impact factor: 5.810

10.  A Toxoplasma gondii Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes.

Authors:  Gustavo D Campagnaro; Hamza A A Elati; Sofia Balaska; Maria Esther Martin Abril; Manal J Natto; Fabian Hulpia; Kelly Lee; Lilach Sheiner; Serge Van Calenbergh; Harry P de Koning
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.